サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1427940

臓器保存液の世界市場レポート 2024年

Organ Preservation Solution Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臓器保存液の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

臓器保存液の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.2%の年間平均成長率（CAGR）で4,060億7,000万米ドルに成長すると予想されます。予測期間中に予想される増加は、拡大基準臓器に対するニーズの高まり、臓器調達プログラムの拡大、臓器の品質と機能の重視、臓器不足への取り組みを目的とした世界の取り組みによってもたらされます。予測期間に予想される主要な動向には、臓器バンクにおける保存液の採用、保存期間の延長に対する市場の焦点、保存を改善するための添加剤の導入、ポータブルでコンパクトな臓器保存装置への集中、研究とイノベーションのための共同努力が含まれます。

予想される臓器移植の急増により、今後数年間で臓器保存液市場の成長が促進されると見られています。臓器移植は、臓器や組織を摘出し、ドナーからレシピエントに移植する外科手術であり、臓器保存液を利用して輸送と保管中の損傷を軽減し、移植を成功させるための臓器の生存率を高めます。たとえば、2023年1月の臓器調達・移植ネットワーク（OPTN）のデータによると、2022年の臓器移植件数は3.7%増加し、合計4万2,887件の手術が2021年の4万1,354件と比較して増加しました。腎臓移植は2万5,000件の手術で大きなシェアを占め、米国では3.4%の成長しました。したがって、臓器移植の増加が臓器保存液市場の主要な原動力となっています。

臓器保存液市場の成長は、医療支出の増加によってさらに促進されています。医療支出、つまり特定の地域、国、組織における医療部門への財政配分の合計は、臓器移植の結果を最適化する上で重要な役割を果たします。 臓器保存液は、輸送と保管中の臓器の生存能力を維持するために不可欠であり、移植手術の成功に貢献します。特に、2023年3月、米国医師協会は、2021年の米国の医療支出が2.7%増加し、4兆3,000億米ドル、つまり1人当たり1万2,914米ドルに達すると報告しました。この医療への投資の高まりは、臓器保存液市場の成長を促進する重要な要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の臓器保存液市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の臓器保存液市場規模実績と成長率、2018～2023年
  • 世界の臓器保存液市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の臓器保存液市場、液タイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • Viaspan
  • Custodiol-HTK（ヒスチジン-トリプトファン-ケトグルタル酸）
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • HBS（高浸透圧血液代替物）液
  • siRNA（低分子干渉RNA）移植液
  • その他
  • 世界の臓器保存液市場、臓器のタイプ別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 腎臓
  • 肝臓
  • 肺
  • 心臓
  • その他
  • 世界の臓器保存液市場、技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
  • 静的低温保管（SCS）技術
  • 低温機器灌流
  • その他

第7章 地域と国の分析

  • 世界の臓器保存液市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
  • 世界の臓器保存液市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 臓器保存液市場の競合情勢
  • 臓器保存液市場の企業プロファイル
    • Bristol-Myers Squibb Company
    • Baxter International Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Accord Healthcare
    • BioLife Solutions Inc.

第31章 その他の大手と革新的な企業

  • Lifeline Scientific
  • TransMedics Group Inc.
  • XVIVO Perfusion AB
  • Organ Recovery Systems Inc.
  • Bridge to Life Ltd.
  • Paragonix Technologies Inc.
  • OrganOx Limited
  • BioTime Inc.
  • Shanghai Genext Pharmaceutical Technology
  • 21st Century Medicine
  • Institut Georges Lopez
  • Carnamedica
  • Global Transplant Solutions
  • Preservation Solutions Inc.
  • Essential Pharmaceuticals LLC

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

目次
Product Code: r13784

Organ preservation solutions are specially formulated solutions designed for the preservation of organs during transplantation or storage. These solutions play a crucial role in safeguarding organs from potential damage during the transplantation process and extending the period for which organs can be stored outside of the body. Organ preservation solutions are formulated with specific agents that aim to mitigate ischemia-reperfusion injury (IRI) by employing targeted mechanisms of action.

There are several main types of organ preservation solutions, including Viaspan, Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, HBS (Hyperosmotic Blood Substitute) Solution, siRNA (Small Interfering RNA) Transplant Solutions, and others. Viaspan, for example, is utilized for the cold storage preservation of solid organs such as the liver, pancreas, and kidneys. It plays a crucial role in maintaining organ viability during transportation and before transplantation. These solutions are employed in preserving various organs, including kidneys, liver, lungs, hearts, and others, utilizing techniques such as static cold storage (SCS) and hypothermic machine perfusion. These preservation techniques are essential for ensuring the successful transplantation of organs and improving overall patient outcomes.

The organ preservation solution research report is one of a series of new reports from The Business Research Company that provides organ preservation solution market statistics, including the organ preservation solution industry's global market size, regional shares, competitors with an organ preservation solution market share, detailed organ preservation solution market segments, market trends and opportunities, and any further data you may need to thrive in the organ preservation solution industry. This organ preservation solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The organ preservation solution market size has grown strongly in recent years. It will grow from $274.48 billion in 2023 to $295.92 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth observed during the historic period in the organ preservation solutions market can be attributed to several factors, including the rise in organ transplants, a growing awareness of organ donation, the expansion of healthcare infrastructure, and an increasing incidence of organ failure. These factors collectively contributed to the increased demand for organ preservation solutions, as they play a critical role in maintaining organ viability during transplantation procedures, improving the chances of successful organ transplantation, and addressing the needs of patients with organ failure.

The organ preservation solution market size is expected to see strong growth in the next few years. It will grow to $406.07 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The anticipated increase during the forecast period is driven by a heightened need for extended criteria organs, the expansion of organ procurement programs, a dedicated emphasis on organ quality and functionality, and global initiatives aimed at tackling organ shortage. Key trends expected in the forecast period involve the adoption of preservation solutions in organ banking, a market focus on extending preservation times, the incorporation of additives for improved preservation, a concentration on portable and compact organ preservation devices, and collaborative efforts for research and innovation in organ preservation.

The anticipated surge in organ transplantation is poised to drive the growth of the organ preservation solution market in the coming years. Organ transplantation, a surgical procedure involving the extraction and transfer of organs or tissues from a donor to a recipient, relies on organ preservation solutions to mitigate damage during transportation and storage, thereby enhancing organ viability for successful transplantation. For instance, data from the Organ Procurement and Transplantation Network (OPTN) in January 2023 revealed a 3.7 percent increase in organ transplants in 2022, totaling 42,887 procedures compared to 41,354 in 2021. Kidney transplants, constituting a significant share with 25,000 procedures, exhibited a 3.4 percent growth in the United States. Consequently, the upswing in organ transplantation is a key driver for the organ preservation solution market.

The growth in the organ preservation solution market is further propelled by increased healthcare spending. Healthcare spending, the total financial allocation to the healthcare sector in a specific region, country, or organization, plays a vital role in optimizing organ transplantation outcomes. Organ preservation solutions are integral to preserving organ viability during transportation and storage, contributing to successful transplant procedures. Notably, in March 2023, the American Medical Association reported a 2.7% increase in health spending in the United States in 2021, reaching $4.3 trillion or $12,914 per capita. This heightened investment in healthcare is a significant factor driving the growth of the organ preservation solution market.

The organ preservation solution market is witnessing a notable trend towards product innovation, with major companies strategically focusing on the development of advanced products to fortify their market positions and gain a competitive edge. An exemplar of this trend is evident in the actions of Paragonix Technologies Inc., a prominent US-based provider of donor organ preservation and transport systems. In October 2021, the company introduced the LIVERguard Donor Liver Preservation System, a cutting-edge preservation and transport system designed for clinical and commercial use in the US and Europe. This system boasts a meticulously regulated and advanced environment for hypothermic liver preservation, incorporating real-time digital monitoring to ensure the safeguarding of a donor's liver throughout the entire transplant process-from donation to transplantation.

Moreover, major companies in the organ preservation solution market are actively pursuing technological advancements, particularly in the realm of organ tracking technology, as a strategic move to enhance their competitive standing in organ transportation. Organ tracking technology involves a spectrum of tools and systems dedicated to monitoring the location and condition of organs during transit. In October 2022, Paragonix Technologies Inc. unveiled its VantagePoint organ tracking technology, providing real-time tracking capabilities for donor organs in transit. This technology aims to enhance transparency and accountability in donor organ transportation, augmenting the digital tracking capabilities offered by the Paragonix App.

In May 2021, Paragonix Technologies Inc. entered into a partnership with Southwest Transplant Alliance, a US-based medical company. This collaborative effort is geared towards delivering cutting-edge organ preservation technology to support the organizations' shared mission of saving lives through organ transplantation and donation. As part of this collaboration, Paragonix will supply clinical support, technology, and information on the advanced preservation features of the PARAGONIX SHERPAPAK CARDIAC TRANSPORT SYSTEM. This strategic partnership underscores the commitment of major players to advance organ preservation solutions and contribute to the progress of organ transplantation initiatives.

Major companies operating in the organ preservation solution market report are Bristol-Myers Squibb Company, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Accord Healthcare, BioLife Solutions Inc., Lifeline Scientific, TransMedics Group Inc., XVIVO Perfusion AB, Organ Recovery Systems Inc., Bridge to Life Ltd., Paragonix Technologies Inc., OrganOx Limited, BioTime Inc., Shanghai Genext Pharmaceutical Technology, 21st Century Medicine, Institut Georges Lopez, Carnamedica, Global Transplant Solutions, Preservation Solutions Inc., Essential Pharmaceuticals LLC, Dr. Franz Kohler Chemie GmbH, Advanced Organ Preservation Solutions (OPSL Group), Vascular Perfusion Solutions Inc., Transplant Biomedicals SL, Claris Lifesciences Limited

North America was the largest region in the organ preservation solution market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the organ preservation solution market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the organ preservation solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The organ preservation solution market consists of sales of the histidine-tryptophan-ketoglutarate solution and hypertonic citrate adenine solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Organ Preservation Solution Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on organ preservation solution market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for organ preservation solution ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The organ preservation solution market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Solution Type: Viaspan; Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate); Renograf; Hypothermosol; Perfadex; Lifor; HBS (Hyperosmotic Blood Substitute) Solution; siRNA (Small Interfering RNA) Transplant Solutions; Other Solution Types
  • 2) By Organ Type: Kidneys; Liver; Lung; Heart; Other Organ Types
  • 3) By Technique: Static Cold Storage (SCS) Technique; Hypothermic Machine Perfusion; Other Techniques
  • Companies Mentioned: Bristol-Myers Squibb Company; Baxter International Inc.; Teva Pharmaceutical Industries Ltd.; Accord Healthcare; BioLife Solutions Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Organ Preservation Solution Market Characteristics

3. Organ Preservation Solution Market Trends And Strategies

4. Organ Preservation Solution Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Organ Preservation Solution Market Size and Growth

  • 5.1. Global Organ Preservation Solution Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Organ Preservation Solution Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Organ Preservation Solution Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Organ Preservation Solution Market Segmentation

  • 6.1. Global Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Viaspan
  • Custodiol-HTK (Histidine-Tryptophan-Ketoglutarate)
  • Renograf
  • Hypothermosol
  • Perfadex
  • Lifor
  • HBS (Hyperosmotic Blood Substitute) Solution
  • siRNA (Small Interfering RNA) Transplant Solutions
  • Other Solution Types
  • 6.2. Global Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kidneys
  • Liver
  • Lung
  • Heart
  • Other Organ Types
  • 6.3. Global Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Static Cold Storage (SCS) Technique
  • Hypothermic Machine Perfusion
  • Other Techniques

7. Organ Preservation Solution Market Regional And Country Analysis

  • 7.1. Global Organ Preservation Solution Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Organ Preservation Solution Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Organ Preservation Solution Market

  • 8.1. Asia-Pacific Organ Preservation Solution Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Organ Preservation Solution Market

  • 9.1. China Organ Preservation Solution Market Overview
  • 9.2. China Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Organ Preservation Solution Market

  • 10.1. India Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Organ Preservation Solution Market

  • 11.1. Japan Organ Preservation Solution Market Overview
  • 11.2. Japan Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Organ Preservation Solution Market

  • 12.1. Australia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Organ Preservation Solution Market

  • 13.1. Indonesia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Organ Preservation Solution Market

  • 14.1. South Korea Organ Preservation Solution Market Overview
  • 14.2. South Korea Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Organ Preservation Solution Market

  • 15.1. Western Europe Organ Preservation Solution Market Overview
  • 15.2. Western Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Organ Preservation Solution Market

  • 16.1. UK Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Organ Preservation Solution Market

  • 17.1. Germany Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Organ Preservation Solution Market

  • 18.1. France Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Organ Preservation Solution Market

  • 19.1. Italy Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Organ Preservation Solution Market

  • 20.1. Spain Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Organ Preservation Solution Market

  • 21.1. Eastern Europe Organ Preservation Solution Market Overview
  • 21.2. Eastern Europe Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Organ Preservation Solution Market

  • 22.1. Russia Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Organ Preservation Solution Market

  • 23.1. North America Organ Preservation Solution Market Overview
  • 23.2. North America Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Organ Preservation Solution Market

  • 24.1. USA Organ Preservation Solution Market Overview
  • 24.2. USA Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Organ Preservation Solution Market

  • 25.1. Canada Organ Preservation Solution Market Overview
  • 25.2. Canada Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Organ Preservation Solution Market

  • 26.1. South America Organ Preservation Solution Market Overview
  • 26.2. South America Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Organ Preservation Solution Market

  • 27.1. Brazil Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Organ Preservation Solution Market

  • 28.1. Middle East Organ Preservation Solution Market Overview
  • 28.2. Middle East Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Organ Preservation Solution Market

  • 29.1. Africa Organ Preservation Solution Market Overview
  • 29.2. Africa Organ Preservation Solution Market, Segmentation By Solution Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Organ Preservation Solution Market, Segmentation By Organ Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Organ Preservation Solution Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Organ Preservation Solution Market Competitive Landscape And Company Profiles

  • 30.1. Organ Preservation Solution Market Competitive Landscape
  • 30.2. Organ Preservation Solution Market Company Profiles
    • 30.2.1. Bristol-Myers Squibb Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Baxter International Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Teva Pharmaceutical Industries Ltd.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Accord Healthcare
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. BioLife Solutions Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Organ Preservation Solution Market Other Major And Innovative Companies

  • 31.1. Lifeline Scientific
  • 31.2. TransMedics Group Inc.
  • 31.3. XVIVO Perfusion AB
  • 31.4. Organ Recovery Systems Inc.
  • 31.5. Bridge to Life Ltd.
  • 31.6. Paragonix Technologies Inc.
  • 31.7. OrganOx Limited
  • 31.8. BioTime Inc.
  • 31.9. Shanghai Genext Pharmaceutical Technology
  • 31.10. 21st Century Medicine
  • 31.11. Institut Georges Lopez
  • 31.12. Carnamedica
  • 31.13. Global Transplant Solutions
  • 31.14. Preservation Solutions Inc.
  • 31.15. Essential Pharmaceuticals LLC

32. Global Organ Preservation Solution Market Competitive Benchmarking

33. Global Organ Preservation Solution Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Organ Preservation Solution Market

35. Organ Preservation Solution Market Future Outlook and Potential Analysis

  • 35.1 Organ Preservation Solution Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Organ Preservation Solution Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Organ Preservation Solution Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer